$64.75
Out of stock
Availability: Expedited shipping if ordered and paid by 12 PM MT
PLEASE NOTE: This product is intended for research use only! This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic. See FDA disclaimers bottom of page.
CJC-1295 with DAC is a synthetic peptide analog referenced in peptide chemistry and molecular signaling research literature. In controlled laboratory environments, this compound is commonly examined in studies involving peptide-receptor interactions, molecular signaling pathways, peptide stability analysis, and structural peptide characterization.
CJC-1295 with DAC peptide is structurally derived from growth hormone–releasing hormone (GHRH). The compound includes a modification known as Drug Affinity Complex (DAC), which allows the peptide to bind to circulating proteins in experimental systems. Because of its defined amino-acid structure and reproducible synthetic profile, CJC-1295 DAC is often included in laboratory studies evaluating peptide signaling behavior and peptide interaction models.
In biochemical research environments, CJC-1295 DAC is referenced in studies examining peptide signaling and receptor binding characteristics. Laboratory investigations involving this peptide may include:
CJC-1295 DAC has been referenced in scientific publications discussing modified GHRH analogs and peptide signaling mechanisms. Within research settings, the compound may be used as a reference peptide when evaluating peptide structure-function relationships and molecular interaction behavior.
CJC-1295 DAC research compounds are commonly supplied in a lyophilized (freeze-dried) format. Lyophilization removes solvent under controlled vacuum and temperature conditions, producing a stable dry peptide preparation suitable for long-term laboratory storage and transport.
Depending on formulation and freeze-drying parameters, the peptide may appear as:
Small variations in appearance between vials are normal and typically reflect minor differences in freeze-drying conditions or formulation composition during production.
Key Molecular AttributesLaboratory preparations of CJC-1295 DAC may include stabilizing excipients designed to preserve peptide integrity during storage and lyophilization. These materials are commonly used in peptide reagent manufacturing and laboratory research compounds.
When reconstituting lyophilized CJC-1295 DAC peptide for laboratory use, solvent composition can influence dissolution characteristics and experimental consistency.
Preservatives or buffering agents present in certain solvents may interact with formulation components. For consistent laboratory preparation, purified laboratory-grade water is frequently used when dissolving peptide compounds.
CJC-1295 DAC is referenced in scientific research involving peptide signaling pathways and receptor interaction analysis. In controlled laboratory experiments, this peptide may be included in research models examining peptide stability, structural peptide behavior, and molecular signaling characteristics.
Because CJC-1295 DAC is a defined synthetic peptide analog, it may be incorporated into laboratory studies investigating:
CJC-1295 DAC peptide should be handled using appropriate sterile laboratory techniques and standard research protocols to maintain sample integrity and experimental reliability.
CJC-1295 DAC is a modified synthetic peptide analog of growth hormone–releasing hormone that contains a Drug Affinity Complex modification referenced in peptide signaling research.
CJC-1295 DAC research compounds are typically supplied as lyophilized powder in sealed laboratory vials to support stability during storage and laboratory preparation.
DAC stands for Drug Affinity Complex, a modification that allows certain peptides to bind to circulating proteins in experimental systems, which can influence molecular stability during research analysis.
You’re reviewing:
You must be 18 years old or older in order to access our website. Please verify your age.
